04 during trading hours on Friday, reaching $0. Start a 14-day free trial to Morningstar Premium to unlock full historical financials. The 50-day moving average for ONTX is significantly below its 200-day moving average. 2% and is now trading at $0. Onconova Therapeutics, Inc. 5% on Tuesday. 2939 f38M We were in the ball park until 11/20 big sell day! What a BEAR trap, s - #5607479. The Onconova Therapeutics stock price gained 2. Post-Market 0. 29 in the recent trade transaction. 20 per share. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Data as of 2021-01-24 12:00:31 -0500 Market Cap: 146. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. 62 and last traded at $0. ONTX Onconova Therapeutics Inc. On 24-02-2020 (Monday), ONTX‘s stock construct a change of -5. Closing Stock Price USD 1. 6% Price as of January 29, 2021, 9:00 p. Onconova Therapeutics, Inc. 36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). It is also -80. 02 per share on revenue of $4. 46 and the lowest ONTX stock price forecast at $0. However, earnings decreased 14. ONTX Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. 785 Weekly candle resistance $0. View Onconova Therapeutics Inc price, streaming chart and supplemental info. The fund acquired 60,000 shares of the biopharmaceutical company’s stock, valued at approximately $41,000. 28 and the avg recommendation for the stock is Hold. Onconova Therapeutics Inc. 7% during mid-day trading on Wednesday. To hit the forecast high, the stock’s price needs a +-6. Get the latest Onconova Therapeutics, Inc. 33% for it to hit the projected low. (ONTX) is up over 29% at $0. 716 Previous Pivot $0. 28% from a day low at $0. However, earnings decreased 14. To hit the forecast high, the stock’s price needs a +-6. Onconova Therapeutics' stock was trading at $0. 46, with a high estimate of 0. Analyst recommendations provided by FactSet shows that the consensus forecast for Onconova Therapeutics Inc. Dow Jones, a News Corp company. (NASDAQ:ONTX)’s stock price shot up 65. Onconova Therapeutics Stock Forecast is based on your current time horizon. Post-Market 0. 82%: One Month Performance -29. The Company operates through the identification and development of oncology therapeutics segment. The stock had previously closed at $0. 55% during the next 3 months and, with a 90% probability hold a price between $0. 34 million loss. 79% and its listed share value at $0. 2021-01-07 09:40 ET - News Release. The median estimate represents a -33. 95 and last traded at $0. To hit the forecast high, the stock’s price needs a -33. To measure stock performance since start of the year, it resulted a change of -17. The average price target represents a -35. Onconova Therapeutics (ONTX) stock revealed 3. 6, 2019: TSLA, ONTX, XHB, BIG, SFIX Benzinga via Yahoo Finance · 1 year ago Benzinga Pro's Stocks To Watch For Friday Tesla (TSLA) - Morgan Stanley analyst Adam Jonas raised his bull-case price target on the stock from $440 to $500. Start a 14-day free trial to Morningstar Premium to unlock full historical financials. Is Onconova Therapeutics a buy right now?. 46 offered by 4 analysts, but current levels are -80. 21% while the S&P 500 is up 18. Each share of common stock (or common stock equivalent) was sold in the offering together with a common warrant to purchase one share of common stock at an exercise price of $0. 04 during trading hours on Friday, reaching $0. Analysts have given the company’s stock an average 52-week price target of $0. BRIEF-Onconova Therapeutics Says Offering Up To 18. ONTX has been the topic of several recent analyst. 5 SP - ONTX price at 2011-01-07 = 0. Volume: 24,426,102: Open: 0. Previous Rating. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. 20 per share. Onconova Therapeutics Stock Forecast is based on your current time horizon. " The 12-month stock price forecast is 0. Revenue grew 4. 46 for the next 12 months. 41 and reached a high price of $0. 66% from the latest price. 46 as the target high. 6% Price as of January 29, 2021, 9:00 p. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. 4 analysts offering their recommendations for the stock have an average rating of 2. Get today's Onconova Therapeutics Inc stock price and latest ONTX news as well as Onconova Therapeutics real-time stock quotes, technical analysis, full financials and more. 46 and a low forecast of $0. On 24-02-2020 (Monday), ONTX‘s stock construct a change of -5. ONTX Streaming Chart Access our live advanced streaming chart forOnconova Therapeutics Inc stock, free of charge. com) is the top online destination for all things Micro-Cap Stocks. Rigosertib is a promising new compound to treat Myelodysplastic. 74 with the day’s price range being $16. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The trend analysis tool will help you make a better prediction on the ONTX stock. rigosertib news, Nov 19, 2013 · An objective look at the new rigosertib study should calm jangled nerves. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. 21% decrease from the last price of $0. Since then, ONTX shares have increased by 97. ONTX disclosed a change of 3. The stock acknowledged active focus on shares in the current trading session. S&P 500 3,714. onconova therapeutics reports q3 2020 results. 7 million with institutional investors in early Jan-21 extends cash runway into late 2022 –sufficient funds for ON. Onconova Therapeutics Inc Stock Price Forecast, "ONTX" Predictons for2021. BRIEF-Onconova Therapeutics Says Offering Up To 18. The consensus estimate was a loss of $0. ONTX has been the topic of several recent analyst. Securities and Exchange Commission reporting information. 4% down from figures reported last year. 7 Million in Registered Direct Offering 10:16AM ET 1/07/2021 MT Newswires. your username. Based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. Ten years of annual and quarterly financial statements and annual report data for Onconova Therapeutics (ONTX). 40 million, a price-to-earnings ratio of -0. 45% on the last day (Friday, 22nd Jan 2021) from $0. 2021 is expected to be a huge year for penny stocks. Announces $8. 12% for it to hit the projected low. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. Shares of ONTX stock traded down $0. The stock acknowledged active focus on shares in the current trading session. ONTX Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. (ONTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. onconova therapeutics reports q3 2020 results. 1 of the analysts rate the stock as a “Buy”. 93% and its listed share value at $0. Stock analysis for Onconova Therapeutics Inc (ONTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ONTX has been the topic of several recent analyst. 69 to a day high of $0. The average price target represents a -35. Data as of 2021-01-24 12:00:31 -0500 Market Cap: 146. Onconova Therapeutics, Inc. Targets $0. StockScouter forecasts that micro cap stocks will be neutral, stocks will be. Common Stock (ONTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get today's Onconova Therapeutics Inc stock price and latest ONTX news as well as Onconova Therapeutics real-time stock quotes, technical analysis, full financials and more. STOCKS ON THE MOVE-Cellectar Biosciences, CASI Pharmaceuticals, Pfizer - Nasdaq Tue, 25 Sep 2018 Onconova Therapeutics Announces Reverse Stock Split Nasdaq:ONTX - GlobeNewswire Wed, 31 Dec 1969 Wed, 31 Dec 1969 Wed, 31 Dec 1969 Wed, 31 Dec 1969. 34 and a beta of 1. (NASDAQ: ONTX) ("Onconova"), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain institutional accredited investors to purchase in a. 21% decrease from the last price of $0. 63 Million by the end of March 2021. The stock had previously closed at $0. com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. 466 USD for 2026 January 29, Thursday. 71591 USD for 2022 January 29, Saturday; and 56. 694 Million: Avg 30-day Volume: 45. Investors can use this forecasting interface to forecast Onconova Therapeutics historical stock prices and determine the direction of Onconova Therapeutics's future trends based on various well-known forecasting models. 5 SP - ONTX price at 2011-01-07 = 0. ONTX stock: Onconova Therapeutics Inc Current Rating. (ONTX) estimates and forecasts. Approximately 67,267,911 shares were traded during trading, a decline of 45% from the average daily volume of 122,410,922 shares. 93% and its listed share value at $0. 980 Gap fill. ONTX Earnings Price Changes. 13% off its SMA20 and 94. This unique "area" or candle chart enables you to clearly notice the movements of this Onconova Therapeutics stock within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. 46 as the target high. January 2021 4 Cash and equivalents as of 9/30/20: $24. The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Quad/Graphics Inc. View Onconova Therapeutics' (NASDAQ:ONTX) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. Income statements, balance sheets, cash flow statements and key ratios. Since then, ONTX shares have increased by 97. Analysts have given the company’s stock an average 52-week price target of $0. The stock had previously closed at $0. Color Star Technology Co Ltd (CSCW Stock Report) Robinhood Penny Stocks to Buy [or avoid]: Onconova Therapeutics Inc. 32 million contracts. 5 Mln Units Of Common Stock, Warrants * ONCONOVA THERAPEUTICS - OFFERING UP TO 18. Previous Rating. Onconova Therapeutics shares last traded at $0. Select chart type, upper and lower indicators, time span from 1 day to 20 years, and more. your username. The stock traded as high as $0. 16% on the last trading day (Tuesday, 26th Jan 2021), rising from $0. 34 and a beta of 1. ONTX stock forecast Our latest prediction for Onconova Therapeutics Inc's stock price was made on the Nov. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. 75% run over in the last seven days. ONTX investment & stock information. ONTX Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. analyst estimates, including ONTX earnings per share estimates and analyst recommendations. Onconova Therapeutics, Inc. Q&A about "ONTX" projections. Based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. 36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). 6% Price as of January 29, 2021, 9:00 p. Recent common-only financing of $8. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change. (ONTX) projections and forecasts Revenue for the current quarter is expected to be $40Million as predicted by 3 analyst (s). On PennyStocks. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. 10 of the Best Stocks to Buy for 2021 The top stocks to buy for 2021 range from small-cap diamonds in the rough to dominant growth stocks. 18% Far from 50 Day Moving Average After a stumble in the market that brought ONTX to its low price for the period of the last 52 weeks, Onconova Therapeutics, Inc. " The 12-month stock price forecast is 0. Approximately 67,267,911 shares were traded during trading, a decline of 45% from the average daily volume of 122,410,922 shares. 40 million, a price-to-earnings ratio of -0. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. : ONTX 56% v76M c. 322 Million: P/E Ratio: Dividend Yield. 46, which is a decrease of -44. The median estimate represents a -33. Onconova Therapeutics,Inc. [ONTX] stock saw a move by -2. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. (ONTX) has a beta value of 2. 33% upsurge from its current level, while the stock would need to tank -33. During that period the price should oscillate between -10. ONTX stock was up 37. Earnings announcements can affect a stock’s price. Is Onconova Therapeutics a buy right now?. Onconova Therapeutics Inc. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. 785 Weekly candle resistance $0. The trend analysis tool will help you make a better prediction on the ONTX stock. Follow along and learn as I perform a quick stock chart technical analysis review on the Onconova Therapeutics, Inc. The stock had previously closed at $0. 20 per share. 71591 USD for 2022 January 29, Saturday; and 56. 82%: One Month Performance -29. There is a lot of buzz around the company’s rigosertib and already ONTX is signing on partners in anticipation it will pass its Phase 3 trial. The stock traded as low as $0. 11% off its average median price target of $0. 6300 (92) Prev. View Onconova Therapeutics, Inc. The stock touched a low price of $0. Get India stock market quotes, stock quote news india, latest share prices for ONTX. 46, with the highest ONTX stock price forecast at $0. Over the last 52 weeks, ONTX is down -64. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 0. View which stocks have been most impacted by COVID-19. 6% Price as of January 29, 2021, 9:00 p. 82%: One Month Performance -29. Webull Financial LLC is a member of SIPC, which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). 46 and high of $0. 6300 (92) Prev. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. 2% and is now trading at $0. 33% for it to hit the projected low. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. Targets $0. 12 per share in November 2019 and continued to at range $0. Shares of ONTX stock traded down $0. 40 million, a price-to-earnings ratio of -0. 20 per share. (ONTX) CEO Steve Fruchtman on Q3 2020 Results - Earnings Call Transcript: Nov 12: Onconova Therapeutics EPS in-line, misses on revenue: Nov 12: Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update: Nov 12: Onconova Therapeutics, Inc. See Onconova Therapeutics, Inc. 36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). In this video I go over how to do a fundamental and technical analysis of ONTX. Get the latest Onconova Therapeutics, Inc. ONTX disclosed a change of 3. Find the latest Onconova Therapeutics, Inc. 92% on Tuesday, touching 3. 46 and a low forecast of $0. 79% and its listed share value at $0. ONTX Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. ONTX Stock Predictions. was unable to take a rebound, for. S&P 500 3,714. The stock traded as high as $0. Unfortunately ONTX wasn’t nearly as popular as these 20 stocks and hedge funds that were betting on ONTX were disappointed as the stock returned -77. Onconova Therapeutics, Inc. 7 Million in Registered Direct Offering 10:16AM ET 1/07/2021 MT Newswires. January 2021 4 Cash and equivalents as of 9/30/20: $24. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 0. 980 Gap fill. 4 analysts offering their recommendations for the stock have an average rating of 2. ONTX disclosed a change of 3. 785 Weekly candle resistance $0. 93% return for the recent month and disclosed -12. The stock had previously closed at $0. Onconova Therapeutic (ONTX) reports earnings on 2/11/2021. your username. Assume you had invested in ONTX stock on 2011-01-07. Common Stock : P - Open market or private purchase: 40,000: $0. Free forex prices, toplists, indices and lots more. The stock has a market cap of $93. Wed, 23 Dec 2020 BUZZ-U. Onconova Therapeutic is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. 36 after the most recent trading session. Onconova Therapeutics (ONTX) stock revealed 3. " The 12-month stock price forecast is 0. 785 Weekly candle resistance $0. The stock touched a low price of $0. Onconova Therapeutics Stock Forecast is based on your current time horizon. Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2021 5:15:48 PM Onconova Therapeutics, Inc. 753 Million: Shares Outstanding: 206. Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Read market forecasts, ONTX financials, economic background and market news. 980 Gap fill. 71591 USD for 2022 January 29, Saturday; and 56. Onconova Therapeutics Inc. Recent common-only financing of $8. EST View Interactive ONTX Charts. 46 and a low estimate of 0. 7 Million Public Offering. 45% on the last day (Friday, 22nd Jan 2021) from $0. 3% as of Tuesday afternoon. 93% and its listed share value at $0. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. rigosertib news, Nov 19, 2013 · An objective look at the new rigosertib study should calm jangled nerves. The median estimate represents a -33. MONECO Advisors LLC acquired a new stake in shares of Onconova Therapeutics, Inc. The average price target is $0. To hit the forecast high, the stock’s price needs a +-6. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. During the day the stock fluctuated 7. 5 SP - ONTX price at 2011-01-07 = 0. 01, and an average true range (ATR) of 0. Onconova Therapeutics' stock was trading at $0. " The 12-month stock price forecast is 0. Onconova Therapeutics (ONTX) said Thursday it will raise $8. Find out if you should buy ONTX stock. In the short term (2weeks), ONTX's stock price should outperform the market by 8. 46, with the highest ONTX stock price forecast at $0. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes, today announced that on August 3, 2020 it received a letter from The Nasdaq Stock Market LLC stating that the Company had regained compliance with. ONTX Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Do NOT follow this link! January 7, 2021 - 9:40 am. 79% and its listed share value at $0. Targets $0. Shares are up 150. In the short term (2weeks), ONTX's stock price should outperform the market by 8. NASDAQ Stocks Under $1 is a list of NASDAQ penny stocks trading under $1. Onconova Therapeutics, Inc. Price Target. nov 12 (reuters) - onconova therapeutics inc ::onconova therapeutics reports third quarter 2020 financial results and provides business. Wed, 23 Dec 2020 BUZZ-U. According to our live Forecast System, Onconova Therapeutics Inc stock is a bad long-term (1-year) investment*. 46 as the target high. The average price target is $0. ONTX Stock Predictions, Articles, and Onconova Therapeutic News. Targets $0. 51 on Tuesday. Color Star Technology Co Ltd (CSCW Stock Report) Robinhood Penny Stocks to Buy [or avoid]: Onconova Therapeutics Inc. 16% on the last trading day (Tuesday, 26th Jan 2021), rising from $0. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. NEWTOWN, Pa. 93% and its listed share value at $0. Based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. Further, Onconova Therapeutics, Inc. Get today's Onconova Therapeutics Inc stock price and latest ONTX news as well as Onconova Therapeutics real-time stock quotes, technical analysis, full financials and more. 46 offered by 4 analysts, but current levels are -80. 260,131,703 shares traded hands during trading, an increase of 76% from the average session volume of 147,582,750 shares. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2021 5:15:48 PM Onconova Therapeutics, Inc. " The 12-month stock price forecast is 0. 6% during the fourth quarter (through the end. If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. Based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. Previous Rating. FinancialContent fully hosted finance channel. The average price target is $0. 980 Gap fill. January 2021 4 Cash and equivalents as of 9/30/20: $24. Wed, 23 Dec 2020 BUZZ-U. 84% increase from the last price of 253. Onconova Therapeutics, Inc. But investors appeared to have thrown those cautions to the wind on Monday morning. Is Onconova Therapeutics a buy right now?. was unable to take a rebound, for. It is also -80. ONTX stock forecast Our latest prediction for Onconova Therapeutics Inc's stock price was made on the Nov. 04% return in 3-month period. View which stocks have been most impacted by COVID-19. Onconova Therapeutics Inc. 50% return in yearly time period. Common Stock (ONTX) at Nasdaq. What Is Return On Capital Employed?. Common Stock : P - Open market or private purchase: 40,000: $0. 5 Mln Units Of Common Stock, Warrants * ONCONOVA THERAPEUTICS - OFFERING UP TO 18. Onconova Therapeutics,Inc. Is ONTX stock a buy or should you stay away? The stock had a rather active trading session with the latest closing, by far recording 2. 273: Aug 31/20: Aug 27/20. "ONTX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. View a customizable chart for a particular stock. View the ONTX U. (ONTX) is up over 29% at $0. Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova Therapeutics Inc Stock Price Forecast, "ONTX" Predictons for2021. To hit the forecast high, the stock’s price needs a +-6. Targets $0. 27, 2020 when the stock price was at 0. 20 per share. 414, prior to closing the session it reached the value of $0. Dow Jones, a News Corp company. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. 28% from a day low at $0. 66% from the latest price. Selected key stats of Onconova Therapeutics, Inc. ONTX Stock Up In Pre-market After Regaining Rights In China January 23, 2020 ONTX stock is moving higher in pre-market action on January 23, 2020, after the company announced that it has regained rights to rigosertib in Greater China. 7 million with institutional investors in early Jan-21 extends cash runway into late 2022 –sufficient funds for ON. If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. Common Stock (ONTX) at Nasdaq. 46, with the highest ONTX stock price forecast at $0. (ONTX) estimates and forecasts. NEWTOWN, Pa. The stock grabbed -41. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to. Onconova Therapeutics, Inc. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. 95 and last traded at $0. If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain. Assume you had invested in ONTX stock on 2011-01-07. Unfortunately ONTX wasn’t nearly as popular as these 20 stocks and hedge funds that were betting on ONTX were disappointed as the stock returned -77. NEWTOWN, Pa. 92% on Tuesday, touching 3. During the day the stock fluctuated 6. Penny Stocks (PennyStocks. The ONTX stock was last observed hovering at around $0. 46 with a high forecast of $0. 21% decrease from the last price of $0. Select chart type, upper and lower indicators, time span from 1 day to 20 years, and more. 19 and a twelve month high of $1. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near future. 7 million with institutional investors in early Jan-21 extends cash runway into late 2022 –sufficient funds for ON. (NASDAQ:ONTX)’s share price dropped 21. Onconova Therapeutics, Inc. 21% while the S&P 500 is up 18. Is ONTX stock a buy or should you stay away? The stock had a rather active trading session with the latest closing, by far recording 2. 29 in the recent trade transaction. StockScouter forecasts that micro cap stocks will be neutral, stocks will be. The price has fallen in 6 of the last 10 days, but is still up by 1. The most recent trading volume of ONTX shares recorded 140. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. Is Onconova Therapeutics a buy right now?. Should I buy or sell ONTX stock? If you are thinking about buying ONTX, make sure you check out the free ONTX stock prediction report provided by MarketClub. nov 12 (reuters) - onconova therapeutics inc ::onconova therapeutics reports third quarter 2020 financial results and provides business. 28% from a day low at $0. 1 of the analysts rate the stock as a “Buy”. 46, forecast between a low of $0. ONTX Stock Analysis Overview What this means: InvestorsObserver gives Onconova Therapeutic (ONTX) an overall rank of 45, which is below average. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Stock analysis for Onconova Therapeutics Inc (ONTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Onconova Therapeutics stock forecast is 8. Shares of ONTX stock opened at $0. 20 per share. There is a lot of buzz around the company’s rigosertib and already ONTX is signing on partners in anticipation it will pass its Phase 3 trial. 8% on a year-over-year basis. SEC filings breakout by MarketWatch. NASDAQ Updated Jan 30, 2021 12:57 AM. 02 per share on revenue of $4. 36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). [ONTX] stock saw a move by -2. Investors can use this forecasting interface to forecast Onconova Therapeutics historical stock prices and determine the direction of Onconova Therapeutics's future trends based on various well-known forecasting models. On PennyStocks. 93%) DOW 29,982. 34% in a total of its share price and finished its trading at 0. To hit the forecast high, the stock’s price needs a -33. The median estimate represents a -33. Onconova Therapeutics, Inc. 00 thousand in revenue during Q2, but reported earnings showed a $7. ONTX finally broke into the gap and may be a runner today. 980 Gap fill. ONTX from the largest community of traders and investors. Onconova Therapeutics Inc Stock Price Forecast, "ONTX" Predictons for2021. ONTX stock was up 37. We cover the US equity market. and has now fallen 5 days in a row. The trend analysis tool will help you make a better prediction on the ONTX stock. This unique "area" or candle chart enables you to clearly notice the movements of this Onconova Therapeutics stock within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. The average price target represents a -35. The median estimate represents a -33. 716 Previous Pivot $0. Free forex prices, toplists, indices and lots more. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. Onconova Therapeutics Inc. 79% and its listed share value at $0. Post-Market 0. Onconova Therapeutics,Inc. 04% return in 3-month period. Onconova Therapeutics (ONTX) stock revealed 3. Stock analysis for Onconova Therapeutics Inc (ONTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 45% on the last day (Friday, 22nd Jan 2021) from $0. Compared to the average trading volume of ONTX shares, the company saw a far better performance. StockScouter forecasts that micro cap stocks will be neutral, stocks will be. Since then, ONTX shares have increased by 97. 46, with a high estimate of 0. Onconova Therapeutics collected $56. Onconova Therapeutics, Inc. 27% from its 50-day simple moving average. 2% and is now trading at $0. nov 12 (reuters) - onconova therapeutics inc ::onconova therapeutics reports third quarter 2020 financial results and provides business. 03 per share on revenue of $0. The price has fallen in 6 of the last 10 days, but is still up by 1. Q&A about "ONTX" projections. The stock acknowledged active focus on shares in the current trading session. (ONTX) has a beta value of 2. ONTX updated stock price target summary. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain. Onconova Therapeutics' stock was trading at $0. [ONTX] stock saw a move by -2. 82%: One Month Performance -29. 33% for it to hit the projected low. To add more color to this target, the company’s high over the last year is $1. 4 analysts offering their recommendations for the stock have an average rating of 2. Onconova Therapeutic (ONTX) reported a 3rd Quarter September 2020 loss of $0. Caution needed as this is quiet a popular name among TWTR pumps. 785 Weekly candle resistance $0. The trend analysis tool will help you make a better prediction on the ONTX stock. Onconova Therapeutics Inc. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. 04 during trading hours on Friday, reaching $0. In the short term (2weeks), ONTX's stock price should outperform the market by 8. ONTX Stock Up In Pre-market After Regaining Rights In China January 23, 2020 ONTX stock is moving higher in pre-market action on January 23, 2020, after the company announced that it has regained rights to rigosertib in Greater China. We cover the US equity market. The company’s stock had a trading volume of 10,926,254 shares, compared to its average volume of 16,342,688. Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. 5: As of Date September 17, 2015: One Year Performance -69. 10 of the Best Stocks to Buy for 2021 The top stocks to buy for 2021 range from small-cap diamonds in the rough to dominant growth stocks. ONTX updated stock price target summary. Since then, ONTX shares have increased by 97. Revenue grew 4. EST View Interactive ONTX Charts. According to analyst projections, ONTX’s forecast low is $0. ONTX Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. NASDAQ: ONTX $0. The ONTX stock was last observed hovering at around $0. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company. To hit the forecast high, the stock’s price needs a -33. 71591 USD for 2022 January 29, Saturday; and 56. The stock traded as high as $0. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. Daren Fonda. During Q3, Onconova Therapeutics (NASDAQ: ONTX) brought in sales totaling $66. com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. 6% Price as of January 29, 2021, 9:00 p. The stock acknowledged active focus on shares in the current trading session. 55% during the next 3 months and, with a 90% probability hold a price between $0. Volume: 24,426,102: Open: 0. 40 million, a price-to-earnings ratio of -0. Previous Rating. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to. Onconova Therapeutics Inc. 2% and is now trading at $0. According to our live Forecast System, Onconova Therapeutics Inc stock is a bad long-term (1-year) investment*. During the day the stock fluctuated 6. Onconova Therapeutics, Inc. Onconova Therapeutics has a twelve month low of $0. On 24-02-2020 (Monday), ONTX‘s stock construct a change of -5. January 2021 4 Cash and equivalents as of 9/30/20: $24. onconova therapeutics reports q3 2020 results. (NASDAQ: ONTX) ("Onconova"), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain institutional accredited investors to purchase in a. NEWTOWN, Pa. ONTX updated stock price target summary. Stock analysis for Denbury Inc (DNR) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 10 of the Best Stocks to Buy for 2021 The top stocks to buy for 2021 range from small-cap diamonds in the rough to dominant growth stocks. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company. The business’s fifty day moving average is $0. (ONTX) shares are trading at lower $0. The Company operates through the identification and development of oncology therapeutics segment. Onconova Therapeutics stock forecast, ONTX price prediction: Buy or sell Onconova Therapeutics, Inc. The Onconova Therapeutics stock forecast is 8. Onconova Therapeutics (ONTX) stock revealed 3. 40 million, a price-to-earnings ratio of -0. 46 and a low forecast of $0. But investors appeared to have thrown those cautions to the wind on Monday morning. Investors can use this forecasting interface to forecast Onconova Therapeutics historical stock prices and determine the direction of Onconova Therapeutics's future trends based on various well-known forecasting models. ONTX Onconova $0. ONTX: Get the latest Onconova Therapeutics stock price and detailed information including ONTX news, historical charts and realtime prices. 89% decrease from the last price of 0. There is a lot of buzz around the company’s rigosertib and already ONTX is signing on partners in anticipation it will pass its Phase 3 trial. 45% on the last day (Friday, 22nd Jan 2021) from $0. nov 12 (reuters) - onconova therapeutics inc ::onconova therapeutics reports third quarter 2020 financial results and provides business. The Onconova Therapeutics stock price fell by -4. ONTX stock forecast Our latest prediction for Onconova Therapeutics Inc's stock price was made on the Nov. Onconova Therapeutics Stock Forecast is based on your current time horizon. 260,131,703 shares traded hands during trading, an increase of 76% from the average session volume of 147,582,750 shares. 46 as the target high. Wed, 23 Dec 2020 BUZZ-U. Shares are up 150. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 111. (NASDAQ: ONTX) ("Onconova"), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain institutional accredited investors to purchase in a. 00 thousand in revenue during Q2, but reported earnings showed a $7. 93% and its listed share value at $0. 37 and a low estimate of 251. 7 million with institutional investors in early Jan-21 extends cash runway into late 2022 –sufficient funds for ON. The stock had previously closed at $0. It is also -80. (NASDAQ:ONTX) ("Onconova"), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that it has entered into a definitive purchase agreement with certain institutional accredited investors to purchase in. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Onconova Therapeutics Inc. The Onconova Therapeutics stock forecast is 8. Investors can use this forecasting interface to forecast Onconova Therapeutics historical stock prices and determine the direction of Onconova Therapeutics's future trends based on various well-known forecasting models. 04% return in 3-month period. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Get today's Onconova Therapeutics Inc stock price and latest ONTX news as well as Onconova Therapeutics real-time stock quotes, technical analysis, full financials and more. 03 per share on revenue of $0. Over the last 52 weeks, ONTX is down -64. 75% run over in the last seven days. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. Welcome! Log into your account. Previous Rating. 45% on the last day (Friday, 22nd Jan 2021) from $0. 46 and high of $0. 71591 USD for 2022 January 29, Saturday; and 56. 13% off its SMA20 and 94. View Onconova Therapeutics Inc price, streaming chart and supplemental info. Advaxis Inc. Latest Trade. Onconova Therapeutics, Inc. 716 Previous Pivot $0. NEWTOWN, Pa. Find out if ONTX is the best investment for you. The stock grabbed -41. Previous Rating. - 1/14/2021 8:00:00 AM. June 10, 2020 6:40 pm ET Nonetheless, Delta reiterated its forecast for revenue to be down 90% in the second quarter, compared with 2019. According to analyst projections, ONTX’s forecast low is $0. Onconova Therapeutics shares last traded at $0. Onconova Therapeutics Inc. 55% during the next 3 months and, with a 90% probability hold a price between $0.